Latest News about TVTX
Recent news which mentions TVTX
From Benzinga
FDA Says Travere's Sparsentan Data Not Sufficient For Accelerated Approval In One Indication
August 04, 2022
Tickers
TVTX
From Benzinga
12 Health Care Stocks Moving In Wednesday's After-Market Session
August 03, 2022
From Benzinga
From Benzinga
HC Wainwright & Co. Maintains Buy Rating for Travere Therapeutics: Here's What You Need To Know
May 17, 2022
Tickers
TVTX
From Benzinga
From Benzinga
From Benzinga
From Benzinga
The Week Ahead In Biotech (April 10-April 16): Regeneron FDA Decision, Cancer Conference Presentations And More
April 10, 2022
From Benzinga
From Benzinga
From Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For February 28, 2022
February 28, 2022
From Benzinga
The Daily Biotech Pulse: Orphazyme Plunges On Regulatory Setback In Europe, Pulmonx Earnings Disappoint, Amicus Declines To Spin Off Genetic Medicine Company
February 24, 2022
From Benzinga
The Week Ahead In Biotech (Feb. 20-26): Reata Awaits FDA Decision, Bausch Health, Moderna Lead Earnings News Flow
February 20, 2022
From Benzinga
Travere Posts Topline Data For Pegtibatinase In patients With Rare Metabolic Disorder
December 15, 2021
Tickers
TVTX
From Benzinga
12 Health Care Stocks Moving In Thursday's After-Market Session
October 28, 2021
From Benzinga
From Benzinga
Earnings Scheduled For October 28, 2021
October 28, 2021
From Benzinga
The Week Ahead In Biotech (Oct. 24-30): Eyenovia, ANI Pharma, Clearside Medical FDA Decisions, Merck, Bristol-Myers Squibb Earnings, IPOs And More
October 24, 2021
From Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.